Yong Kang is an assistant professor at the Department of Pathology and Laboratory Medicine. He completed his undergraduate education at Shanghai Medical University in Shanghai, China, where he also received his MD. He received his PhD from SUNY-Upstate Medical University. He completed fellowships at the Johns Hopkins School of Medicine, Department of Orthopedic Surgery, and Saint Barnabas Medical Center/Monmouth Medical Center, Department of Pathology.

His areas of interest include rapid molecular identification of pathogenic microorganisms, growth and differential factors, and bone morphogenetic proteins and gene regulations.

Hospital Affiliations

  • Robert Wood Johnson University Hospital - New Brunswick, NJ

Licensure

  • State of New Jersey
  • State of New York

Certifications

  • American Board of Pathology: Certified in Anatomic and Clinical Pathology

Publications

Book/Chapter

A.H. Reddi and Yong Kang. (1996). Bone Morphogenetic Protein. In: Human Cytokines. Vol. II: 422-437. (B. B. Aggarwal and J. U. Gutterman, Eds) Blackwell Scientific Publication. Cambridge, MA.

Journals

  1. Jialing Huang, M.D., Eli Balshan, M.D., Yong Kang, M.D., Ph.D. Approach to Crystalline Material in Granulomas of Gastrointestinal Pathology. 2018 (manuscript in preparation).
  2. Merchant C, Villanueva DD, Lalani I, Eng M, Kang Y. (2016). PBP-2 Negative Methicillin Resistant Staphylococcus schleiferi Bacteremia from a Prostate Abscess: An Unusual Occurrence. Case Rep Infect Dis. 2016;2016:8979656
  3. Nicole Saviano, M.D., Yi-Wei Tang, M.D., Ph.D., Yong Kang, M.D., Ph.D. (2009) Co-presence of Epstein-Barr virus and human papilloma virus 16 in lymphoepithelioma-like carcinoma of the uterine cervix. Arch Pathol Lab Med. 133: 1608-1716(a).
  4. Jaimini Vora, M.D., Dominick A. LoBraico, D.O., Yong Kang, M.D., Ph.D. (2009) Intrauterine Fetal Demise Caused By Thymic Hyperplasia and Cardiovascular Compromise. Arch Pathol Lab Med. 133: 1608-1716(a).
  5. S. Drury, W. Alpaugh, X. Han, Y. Kang. (2006) Rapid Identification of Mycobacterium species in Difficult and Contaminated Clinical Specimen by DNA Sequencing Method. Am J Clin Pathol. 126:651-652 (a).
  6. Yong Kang, M.D., Ph.D. (2003) Cyclin E in Breast Cancer. New Engl J Med. 348:1063 (correspondence).
  7. Yong Kang, Michael Wile and Roger Schinella. (2001) Gynecomastia-Like Changes of Female breast, A Clinicopathologic Study of 4 Cases. Arch Pathol Lab Med. 125:506-509.
  8. Yong Kang and David R. Mitchell. (1998) An Intronic enhancer is Required for Deflagellation-induced Transcription Regulation of a Chlamydomonas reinardtii Dynein Gene. Molecular Biology of the Cell. 9, 3085-3094.
  9. Yong Kang, A. H. Reddi. (1996) Identification and Cloning of a Novel Type I serine/threonine kinase Receptor of the TGF-beta/BMP superfamily in Rat Prostate. Biochem Mol Biol Int. 40(5), 993-1001.
  10. D. R. Mitchell and Yong Kang. (1993). Reversion Analysis of Dynein Intermediate Chain Function. Journal of Cell Science. 105:1069-1078.
  11. D. R. Mitchell and Yong Kang. (1991). Identification of oda6 as a Chlamydomonas Dynein Mutant by Rescue with the Wild-type Gene. J. Cell Biol. 113:835-842.

Presentation

  1. Kim BK, Alpaugh W, Kang Y. Selective Enrichment Broth Culture Increased the Toxigenic Clostridium difficile Detection Rate of a Dual Antigen and Toxin A/B EIA Assay by 54.4%, 110th General Meeting of American Society of Microbiology, San Diego, May 25, 2010
  2. Dongmin Gu1, Sherif Eltawansy2, Monica Shah3, Weldon Alpaugh1, Margaret Eng2, Yong Kang1 Clinical Impact of the Rapid FilmArray Blood Culture Identification in Intensive Care Units of a Community Hospital (2015 Ellen Cosgrove Award 1st place)